Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.

Nguyen G, Blanchard A, Curis E, Bergerot D, Chambon Y, Hirose T, Caumont-Prim A, Tabard SB, Baron S, Frank M, Totsune K, Azizi M.

Hypertension. 2014 Feb;63(2):297-302. doi: 10.1161/HYPERTENSIONAHA.113.02217. Epub 2013 Nov 11.

2.

Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.

Stankovic AR, Fisher ND, Hollenberg NK.

J Am Soc Nephrol. 2006 Dec;17(12):3293-9. Epub 2006 Nov 8.

3.

Reduced plasma aldosterone concentrations in randomly selected patients with insulin-dependent diabetes mellitus.

Cronin CC, Barry D, Crowley B, Ferriss JB.

Diabet Med. 1995 Sep;12(9):809-15.

PMID:
8542742
4.

Plasma levels of prorenin and renin in blacks and whites: their relative abundance and associations with plasma aldosterone concentration.

Tu W, Eckert GJ, Pratt JH, Jan Danser AH.

Am J Hypertens. 2012 Sep;25(9):1030-4. doi: 10.1038/ajh.2012.83. Epub 2012 Jun 14.

PMID:
22695510
5.

The relationship between active renin concentration and plasma renin activity in Type 1 diabetes.

Valabhji J, Donovan J, Kyd PA, Schachter M, Elkeles RS.

Diabet Med. 2001 Jun;18(6):451-8.

PMID:
11472463
6.

Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.

Recarti C, Seccia TM, Caroccia B, Gonzales-Campos A, Ceolotto G, Lenzini L, Petrelli L, Belloni AS, Rainey WE, Nussberger J, Rossi GP.

J Hypertens. 2015 May;33(5):1014-22. doi: 10.1097/HJH.0000000000000504.

PMID:
25668351
7.

The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.

Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK.

Am J Hypertens. 1999 Apr;12(4 Pt 1):348-55.

PMID:
10232494
9.

Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.

Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH.

Am J Hypertens. 1999 May;12(5):451-9.

PMID:
10342782
10.

Validity of the aldosterone-renin ratio used to screen for primary aldosteronism.

Montori VM, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST.

Mayo Clin Proc. 2001 Sep;76(9):877-82.

PMID:
11560297
11.

Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.

van den Heuvel M, Batenburg WW, Jainandunsing S, Garrelds IM, van Gool JM, Feelders RA, van den Meiracker AH, Danser AH.

J Hypertens. 2011 Nov;29(11):2147-55. doi: 10.1097/HJH.0b013e32834bbcbf.

PMID:
21941204
12.
13.

Hyperaldosteronism among black and white subjects with resistant hypertension.

Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P.

Hypertension. 2002 Dec;40(6):892-6.

14.

Low plasma aldosterone despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation.

Luik PT, Kerstens MN, Hoogenberg K, Navis GJ, Dullaart RP.

Eur J Clin Invest. 2003 Sep;33(9):787-93.

PMID:
12925038
15.

Aldosterone and left ventricular hypertrophy in Afro-Caribbean subjects with low renin hypertension.

Stewart AD, Millasseau SC, Dawes M, Kyd PA, Chambers JB, Ritter JM, Chowienczyk PJ.

Am J Hypertens. 2006 Jan;19(1):19-24.

PMID:
16461185
16.

Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.

Berge C, Courand PY, Harbaoui B, Paget V, Khettab F, Bricca G, Fauvel JP, Lantelme P.

J Hypertens. 2015 Jan;33(1):118-25. doi: 10.1097/HJH.0000000000000367.

PMID:
25333683
17.

Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy.

Deinum J, Tarnow L, van Gool JM, de Bruin RA, Derkx FH, Schalekamp MA, Parving HH.

Nephrol Dial Transplant. 1999 Aug;14(8):1904-11.

PMID:
10462269
18.

Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.

Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H.

J Hypertens. 1998 Jun;16(6):853-62.

PMID:
9663926
19.

Renin and prorenin have no direct effect on aldosterone synthesis in the human adrenocortical cell lines H295R and HAC15.

Jansen PM, Hofland J, van den Meiracker AH, de Jong FH, Danser AH.

J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):360-6. doi: 10.1177/1470320312438792. Epub 2012 Mar 6.

PMID:
22396488

Supplemental Content

Support Center